ESAB Corporation ESAB 深 滬
已收盤 02-06 16:00:00 美东时间
134.05
+6.150
+4.81%
華盛通- 最 高135.41
- 今 開129.58
- 成交量 109.16万股
- 最 低 128.41
- 昨 收 127.90
- 總市值 83.06亿
- 52周最高 135.64
- 市盈率 靜 31.09
- 換手率 1.76%
- 52周最低 99.8653
- 委 比 4.55%
- 總股本 6196.52万
- 歷史最高 135.64
- 量 比 1.08
- 振 幅 5.47%
- 歷史最低 31.16
- 每 手 1
- 風險率 6.52%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅213.87%！Wave Life Sciences获Canaccord Genuity升目标价至43美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences Ltd."买入"评级，目标价从40美元升至43美元；花旗：维持Palantir Technologies"买入"评级，目标价从235美元升至260美元
02-04 12:15
JP Morgan Maintains Overweight on ESAB, Lowers Price Target to $130
JP Morgan analyst Tami Zakaria maintains ESAB (NYSE:ESAB) with a Overweight and lowers the price target from $138 to $130.
02-04 01:58
ESAB Targets $5 Billion TAM Growth Through Eddyfi Buyout
ESAB shares fell after announcing the $1.45B acquisition of Eddyfi Technologies, set to close mid-2026, expanding revenue, margins, and high-growth market exposure.
02-03 02:27
ESAB Corp. shares are trading lower after the company issued FY25, FY26 EPS guidance below estimates.
ESAB Corp. shares are trading lower after the company issued FY25, FY26 EPS gui...
02-03 01:48
ESAB Announces Eddyfi Acquisition and Financing Initiatives
ESAB Corporation ( ($ESAB) ) just unveiled an announcement. On January 31, 2026...
02-02 20:20
ESAB Corp Expects Q4 Revenue Of $720M-$722M Vs $707.67M Est, Adj EPS Of $1.34-$1.36 Vs $1.35 Est
ESAB Corporation ("ESAB" or the "Company") (NYSE:ESAB), a focused premier industrial compounder, today announced that it has signed a definitive agreement to acquire Eddyfi Technologies ("Eddyfi"), a global leader in
02-02 19:54
ESAB to Buy Eddyfi Technologies for $1.45B in Major Industrial Deal
ESAB Corporation ("ESAB" or the "Company") (NYSE:ESAB), a focused premier industrial compounder, today announced that it has signed a definitive agreement to acquire Eddyfi Technologies ("Eddyfi"), a global leader in
02-02 19:50
美股大行评级 | 英特尔绩后获多家大行上调目标价；理想汽车、Mobileye、Meta、微软、甲骨文等遭下调目标价
今日重点评级关注：RBC Capital：维持Compass Pathways"跑赢大市"评级，目标价从16美元升至21美元；RBC Capital：维持GH Research"跑赢大市"评级，目标价从33美元升至40美元
01-26 14:32
Oppenheimer Maintains Outperform on ESAB, Raises Price Target to $148
Oppenheimer analyst Bryan Blair maintains ESAB (NYSE:ESAB) with a Outperform and raises the price target from $142 to $148.
01-23 22:18
美股大行评级 | 英特尔、美光科技、SanDisk等获大行上调目标价；纽约梅隆银行获5家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Rezolve AI"买入"评级，目标价从10美元升至12美元；HC Wainwright & Co.：维持Largo"买入"评级，目标价从2.9美元升至3.1美元
01-15 16:10
